Scarica l'app Stockscreener
7.80
4.70%
0.35
Dopo l'orario di chiusura:
7.91
0.11
+1.41%
Precedente Chiudi:
$7.45
Aprire:
$7.72
Volume 24 ore:
117.69K
Relative Volume:
1.63
Capitalizzazione di mercato:
$447.39M
Reddito:
$154.57M
Utile/perdita netta:
$15.07M
Rapporto P/E:
28.89
EPS:
0.27
Flusso di cassa netto:
$10.92M
1 W Prestazione:
+0.26%
1M Prestazione:
+8.33%
6M Prestazione:
+10.17%
1 anno Prestazione:
+34.95%
Intervallo 1D:
$7.66
$7.82
Intervallo di 1 settimana:
$7.37
$7.86
Portata 52W:
$5.08
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Confronta KMDA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.80 | 447.39M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
147.37 | 69.30B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 47.50B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.53 | 44.47B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.31 | 18.83B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.12 | 13.43B | 2.99B | 1.21B | 1.13B | 25.06 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Iniziato | The Benchmark Company | Buy |
| 2024-07-03 | Iniziato | Stifel | Buy |
| 2018-02-02 | Iniziato | Chardan Capital Markets | Buy |
Kamada Ltd Borsa (KMDA) Ultime notizie
Kamada Ltd. Stock Analysis and ForecastAccelerated investment success - PrintWeekIndia
What analysts say about Kamada Ltd. stockOutstanding risk-reward balance - jammulinksnews.com
Is Kamada Ltd. a good long term investmentUnprecedented profit potential - Autocar Professional
What drives Kamada Ltd. stock priceExceptional stock performance - jammulinksnews.com
Why Kamada Ltd. stock attracts strong analyst attentionFree Real-Time Trading Opportunities - Newser
What makes Kamada Ltd. stock price move sharplyTrend Following Trades - Newser
How Kamada Ltd. stock performs during market volatilityProfitable Yet Secure Picks - Newser
Emphysema Pipeline 2025: MOA, ROA, and Clinical Trial Insights - openPR.com
Emphysema Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | Kamada, Ltd., Hoffmann-La Roche, Aeris Therapeutics, Grifols Therapeutics, Sanofi - The Globe and Mail
Emphysema Pipeline 2025: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight Kamada, Ltd., Hoffmann-La Roche, Aeris Therapeutics, Grifols Therapeutics, Sanofi - Menafn.com
Is Kamada (KMDA) Stock Undervalued Right Now? - Nasdaq
Kamada confirms continuous business operations despite recent events in Middle East - MSN
Should Value Investors Buy Kamada (KMDA) Stock? - Yahoo Finance
Kamada Confirms Continuous Global Business Operations and - GlobeNewswire
Kamada Ensures Global Operations Amid Middle East Tensions - TipRanks
Kamada confirms continuous business operations despite Middle East events - TipRanks
Kamada Confirms No Supply Disruptions: How Israeli Biotech Giant Safeguards Global Product Availability - Stock Titan
Plasma Therapeutics Market Revenue to Attain USD 46.46 Bn by 2033 - Precedence Research
Kamada Reports Strong Q1 2025 Growth with Plasma Business Expansion and Key Milestones - citybuzz -
Implied Volatility Surging for Kamada Stock Options - Yahoo Finance
Kamada Intensifies Efforts to Highlight CYTOGAM's Role in Combatting CMV in Organ Transplant Patients - citybuzz -
Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM - FinancialContent
Millennium Management LLC Sells 36,872 Shares of Kamada Ltd. (NASDAQ:KMDA) - Defense World
Are Investors Undervaluing Kamada (KMDA) Right Now? - Yahoo Finance
Alpha-1 Antitrypsin Deficiency Market: Epidemiology, - openPR.com
Kamada (NASDAQ:KMDA) Stock Crosses Below 200 Day Moving Average – What’s Next? - Defense World
Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World
Kamada's (TLV:KMDA) Solid Earnings Are Supported By Other Strong Factors - simplywall.st
Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm - The Manila Times
HC Wainwright Issues Optimistic Outlook for Kamada Earnings - Defense World
Sidoti Csr Has Optimistic Outlook of Kamada FY2025 Earnings - Defense World
Kamada’s (KMDA) Buy Rating Reiterated at Benchmark - Defense World
Kamada Ltd. (NASDAQ:KMDA) Q1 2025 Earnings Call Transcript - MSN
Wall Street Analysts Believe Kamada (KMDA) Could Rally 106.56%: Here's is How to Trade - Yahoo Finance
Kamada Ltd’s Earnings Call Highlights Strong Growth and Expansion - TipRanks
Kamada (KMDA) Receives Reiterated Buy Rating from Benchmark | KM - GuruFocus
Kamada (KMDA) Receives Reiterated Buy Rating from Benchmark | KMDA Stock News - GuruFocus
Benchmark maintains Kamada stock Buy rating with $15 target By Investing.com - Investing.com Nigeria
Kamada: Q1 Earnings Snapshot - CT Insider
Kamada Ltd Azioni (KMDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.97%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):